| Literature DB >> 22036947 |
Timo Schwandt1, Beatrix Schumak, Gerrit H Gielen, Frank Jüngerkes, Patricia Schmidbauer, Katrin Klocke, Andrea Staratschek-Jox, Niko van Rooijen, Georg Kraal, Isis Ludwig-Portugall, Lars Franken, Sven Wehner, Jörg C Kalff, Olaf Weber, Carsten Kirschning, Christoph Coch, Ulrich Kalinke, Jörg Wenzel, Christian Kurts, Rainer Zawatzky, Bernhard Holzmann, Laura Layland, Joachim L Schultze, Sven Burgdorf, Joke M M den Haan, Percy A Knolle, Andreas Limmer.
Abstract
Early during Gram-negative sepsis, excessive release of pro-inflammatory cytokines can cause septic shock that is often followed by a state of immune paralysis characterized by the failure to mount adaptive immunity towards secondary microbial infections. Especially, the early mechanisms responsible for such immune hypo-responsiveness are unclear. Here, we show that TLR4 is the key immune sensing receptor to initiate paralysis of T-cell immunity after bacterial sepsis. Downstream of TLR4, signalling through TRIF but not MyD88 impaired the development of specific T-cell immunity against secondary infections. We identified type I interferon (IFN) released from splenic macrophages as the critical factor causing T-cell immune paralysis. Early during sepsis, type I IFN acted selectively on dendritic cells (DCs) by impairing antigen presentation and secretion of pro-inflammatory cytokines. Our results reveal a novel immune regulatory role for type I IFN in the initiation of septic immune paralysis, which is distinct from its well-known immune stimulatory effects. Moreover, we identify potential molecular targets for therapeutic intervention to overcome impairment of T-cell immunity after sepsis.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22036947 PMCID: PMC3252580 DOI: 10.1038/emboj.2011.380
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598